News

Filter

Current filters:

BG-12

Positive trial results for Biogen Idec's MS drug BG-12

21-09-2012

US biotech firm Biogen Idec (Nasdaq: BIIB) says that data from the Phase III DEFINE and CONFIRM studies…

BG-12Biogen IdecBiotechnologydimethyl fumarateNeurologicalResearch

COMPANY SPOTLIGHT

Menarini

Back to top